Literature DB >> 9836758

A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months.

P L Kolominsky-Rabas1, C Sarti, P U Heuschmann, C Graf, S Siemonsen, B Neundoerfer, A Katalinic, E Lang, K G Gassmann, T R von Stockert.   

Abstract

BACKGROUND AND
PURPOSE: In Germany, basic data on stroke morbidity are lacking. If a population-based register in former East Germany is excluded, only routine mortality statistics have thus far provided information on epidemiology of stroke. Therefore, a population-based register of stroke was set up in Southern Germany to determine incidence and case fatality in a defined German population.
METHODS: The Erlangen Stroke Project (ESPro) is a prospective community-based study among the 101 450 residents of the city of Erlangen, Bavaria, Germany. Standard definitions and overlapping case-finding methods were used to identify all cases of first-ever stroke in all age-groups, occurring in the 2 years of registration (April 1, 1994, to March 31, 1996). All identified cases of first-ever strokes were followed up at 3 and 12 months from onset.
RESULTS: During 2 years of registration, 354 first-ever-in-a-lifetime strokes (FELS) were registered. The diagnosis and stroke type were confirmed by CT scan in 95% of cases. Fifty-one percent of all FELS occurred in the age group >/=75 years of age. The crude annual incidence rate was 1.74 per 1000 (1.47 for men and 2.01 for women). After age-adjustment to the European population, the incidence rate was 1.34 per 1000 (1.48 for men and 1. 25 for women). The annual crude incidence rate of cerebral infarction was 1.37/1000, intracerebral hemorrhage 0.24/1000, subarachnoid hemorrhage 0.06/1000, and unspecified stroke 0.08/1000. Overall case fatality at 28 days was 19.4%, at 3 months it was 28.5%, and at 1 year 37.3%.
CONCLUSIONS: The first prospective community-based stroke register including all age groups in Germany revealed incidence rates of stroke similar to those reported from other population-based studies in western industrialized countries, but lower than that observed in former East Germany.

Entities:  

Mesh:

Year:  1998        PMID: 9836758     DOI: 10.1161/01.str.29.12.2501

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  64 in total

1.  Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply.

Authors:  Alexander Katalinic; Elke Peters; Fritz Beske; Ron Pritzkuleit
Journal:  Transfus Med Hemother       Date:  2010-05-20       Impact factor: 3.747

2.  Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly.

Authors:  Michal Rozanski; Martin Ebinger; Wolf U Schmidt; Benjamin Hotter; Sandra Pittl; Peter U Heuschmann; Jan G Jungehuelsing; Jochen B Fiebach
Journal:  Eur Radiol       Date:  2010-07-21       Impact factor: 5.315

3.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

4.  [Quality of life and disability after severe stroke and early neurological rehabilitation].

Authors:  Günter Seidel; Amely Röttinger; Jürgen Lorenzen; Detmar Kücken; Anja Majewski; Karsten Klose; Christoph Terborg; Irina Klass; Peter Wohlmuth; Elke Zukunft; Ulf Debacher
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

5.  [Symptoms, risk factors, and etiology of transient ischemic attack and stroke].

Authors:  C H Nolte; J Müller-Nordhorn; G J Jungehülsing; K Rossnagel; A Reich; M Klein; S N Willich; A Villringer
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

6.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

7.  [Development of mortality and morbidity of vascular diseases: variations between coronary heart disease and stroke].

Authors:  P U Heuschmann; H K Neuhauser; M Endres
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

8.  Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life.

Authors:  Tobias Back; Steffi Grünig; Yaroslav Winter; Ulf Bodechtel; Kersten Guthke; Diana Khati; Rüdiger von Kummer
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

Review 9.  Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends.

Authors:  N K de Rooij; F H H Linn; J A van der Plas; A Algra; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

10.  Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept).

Authors:  Carina Hohmann; Roland Radziwill; Juergen M Klotz; Andreas H Jacobs
Journal:  Health Qual Life Outcomes       Date:  2010-06-18       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.